Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc. (Nasdaq: PWUP) is a blank-check company focused on acquisition opportunities in the biopharma and life sciences sector. The company filed an 8-K with the SEC on April 16, 2026, reflecting continued corporate activity as it advances toward a qualifying business combination. Biopharma-focused SPACs occupy a distinct segment of the blank-check market, seeking to pair public-market capital with private pharmaceutical and biotech targets navigating the path to a listed exchange. PWUP remains an active vehicle within that healthcare-deal pipeline. For comprehensive filing history, status tracking, and comparable-transaction analytics on PWUP and the broader SPAC universe, sign up for full data access at SpacDesk.